Joseph has been a practicing clinical perfusionist for 40 years. Currently, Joseph is the CEO of Houston Extracorporeal Technologies and is the program director of The New Orleans Conference and MediWeb which includes PerfWeb and NurseWeb.
Lucas M. Duvall, MD, FACS is a board-certified and fellowship trained cardio-thoracic surgeon and a fellow in the American College of Surgeons. Dr. Duvall is the Houston Methodist The Woodlands Hospital Cardiovascular Surgery Medical Director and the Vice President of the Medical Staff.
Dr. Prakash Balan is a board certified Physician and Assistant Professor for the Department of Internal Medicine at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).
John Ingram is a magna cum laude graduate from University of Texas, Texas Heart Institute and a board certified perfusionist currently specializing in adult perfusion as well as pediatric and adult ECMO. He has several medical patents and has served as a consultant for nearly every perfusion manufacturer. He has published seven research publications in the perfusion literature, and has presented both nationally and internationally. With fifteen years experience as a Chief Perfusionist, and thirty years perfusion experience in total, he presently provides nationwide temporary and long term locum tenens coverage.
Samolyk first started working in Perfusion in 1989 at Johns Hopkins
and has worked in the Mid-Atlantic and New England and he is still
very involved with the field in many ways. He is currently the
Liaison to the Blood Management Medical Community of SABM and its
Networks for AMSECT as well is the AABB Liaison for Perfusionist from
AmSECT. He is a Director for the International Board of Blood
Management (IBBM) and a Certified PBMS (Patient Blood Management
Specialist), He was on the Steering Committee for “NABM” New
Advances in Blood Management organizing Perfusion meetings in Jackson
Hole and Kansas City for ten years. He is a Past Chair of the SABM
Perfusion Blood Education Committee, was on the Guideline writing
committee ICEBP International Board of Evidence Based Best Practices.
Has authored peer reviewed publications and guidelines. He has
Developed, Patented, and brought to market an innovative Blood
Salvaging Device and Method for Saving Autologous Whole Blood in
Surgery with sales in the USA, Canada and Globally Abroad. He has
received the AABB’s highest award the Dale E. Smith Award for
Innovation Pioneer in Blood Conservation from the National Blood
foundation. Currently he serve full time as the President and CEO of
“Global Blood Resources” and is chairman of the Board.
Dr. Hany Samir is the founder and CEO of HS Consulting for Telehealth, Assistant
Professor of Cardiovascular Anesthesiology and Critical Care with Weill Cornell
Medical College at the DeBakey Heart and Vascular Center at Houston Methodist
Hospital. He is an established and highly skilled physician with over 33 years of
experience in Critical/Intensive Care, Cardiovascular Medicine, Anesthesiology,
Emergency Medicine, and Peri-operative Surgery including transplant. He is well
regarded in the Houston, TX community, earning numerous accolades for his
commitment to quality and patient centered care. Dr. Samir is licensed in 5 states and
is double board certified in Critical Care Medicine and Anesthesiology. He is an
esteemed fellow of the Cardiac Renal Society and the American College of Chest
Physicians. He is also active in the Extracorporeal Life Support Organization, Texas
Society of Anesthesiology, Society of Critical Care Medicine, and the Society of
Dr. Samir has published in the areas of mechanical circulatory support in severe shock
patients, ECMO, severe sepsis, peri-operative LVAD management as destination
therapy and bridge to transplant, post-operative bleeding management, acute
hypertensive management in post-operative aortic arch repair, and rapid reversal of
anticoagulation in post-surgical complications.
Dr. Samir is an expert in critical care as well as peri-operative management and has
been one of the first in the country to adopt and apply his expertise into telemedicine.
He has created a national reputation for quality and is highly respected as an expert
consultant regarding how to implement critical care with telehealth technology. This
new and growing technology can be implemented into health care systems to provide
and improve quality of care without compromising outcomes. The future of medicine
will be in digital platforms with medical innovations and Dr. Samir has become an
expert on how to incorporate these new technologies into medical facilities who want
to transform their types of services to align with the future of health care.
William J. DeBois, CCP, MBA is Perioperative Services Director and Chief Perfusionist at New York Presbyterian Hospital-Weill Cornell Medical Center in New York City. After graduating from State University of New York at Stony Brook, he started his career in Brooklyn, NY and after seven years moved to Cornell. In his almost 37 years as a perfusionist, his programs have performed over 45,000 open-heart procedures. Bill’s passion for perfusion technology led him to work in blood conservation and safety for which he has over 100 publications and presentations.
He has been active in AmSECT and currently he serves as President. Additionally he has been involved with perfusion licensure and served as Chair of the licensing committee in New York.
As President of AmSECT Mr. DeBois has worked hard to get more perfusionists involved in the professional organization and has helped to improve membership to over 2000 members. He continues to work at improving membership and helping to engage perfusionists to adopt AmSECT’s standards and guidelines. Bill believes that this will improve the performance of perfusionists and ultimately improve the care of patients undergoing cardiopulmonary bypass.
Dr. Gersak is a full Professor of Surgery, University of Ljubljana, Medical Faculty and Department of Cardiovascular Surgery at University Medical Center Ljubljana, Slovenia. He is active in the cardiovascular medicine for more than 35 years and published more than 500 peer reviewed papers and presentations on various topics in cardiac surgery. He organized and chaired many international surgical meetings around the world, including European Congress of Cardiovascular Surgery and World Congress of Cardiothoracic, Vascular and Endovascular Surgery. His main interest is minimally invasive cardiac surgery for mitral and aortic valve pathology, as well as atrial fibrillation. He was visiting professor in various institutions around the world, including Tel Aviv (Israel), Sao Paolo (Brazil), Ryhadh (Saudi Arabia), Kuala Lumpur (Malaysia), and served as proctor and master proctor for Edwards, Atricure and Sorin-Livanova. At the present moment he is very active in USA and Japan.
Perme, PT CCS FCCM is the owner of Perme ICU Rehab Seminars and a
Clinical Development Specialist at the Houston Methodist Hospital,
where she has practiced for the past 32 years with a large variety of
complex patients in ICU.In 2005 she became a Cardiovascular and
Pulmonary Clinical Specialist. In 2017, she was accepted as a Fellow of
the American College of Critical Care Medicine, the
first physical therapist in the world to receive such recognition.
Perme has published 18 articles and is co-author in 9 book chapters.
She has extensive experience in treating adult patients in ICU
with special interest in patients on mechanical ventilation. Mrs. Perme
has presented hundreds of courses and lectures in the United States.
She is also a world-renowned speaker with presentations in Colombia
(2017), Puerto Rico and Germany (2016), Denmark
(2015), Russia (2014), Brazil (2015, 2013, 2012, 2010), Nigeria (2011),
and at the World Physical Therapy Congress (Netherlands-2011,
After 21 years of perfusion, Roger went to the dark side as a clinical specialist, and has worked with ECMO units across the US. His recent work has focused on oxygenator clotting and recirculation. He is currently in the process of leaving industry and returning to perfusion full time.
I graduated from Butler University in 1988 with a degree in Zoology/Pre-Med. I then completed training as a registered respiratory therapist, and practiced for about 5 years, mainly in critical care. During that time, I observed an open heart surgery case, and decided to pursue a career as a perfusionist. I graduated from the first class of the Cleveland Clinic/Ohio State school of Cardiovascular Perfusion program in 1995. I presented my student research project at the AmSECT meeting in 1995, which was given the award for “Best First Time presenter” as well as the AmSECT Research Award for “Exceptional Original Research published in The Journal of Extracorporeal Technology”, for work in pumpless A-V carbon dioxide removal in acute lung injury. In 2010, I spent about 3 and half years as a clinical specialist for VAD Company starting their US clinical trial. I returned to full time clinical perfusion in 2013 as a mechanical circulatory support coordinator for the University of Louisville Physicians department of Cardiovascular and Thoracic Surgery. I mainly focus now in adult clinical perfusion, ECMO, ventricular assist devices, adult clinical perfusion and MCS, and when required, pediatric VADs.
Graduated with degree in medicine at the University of Amsterdam. PhD research with prof. Can Ince at the department of Clinical Physiology of the University of Amsterdam Academic Medical Center. An early care investigator pushing the relevance of the microcirculation into clinical practice. (Co-)Authored numerous papers on the microcirculation in leading medical journals like the Lancet, Applied Physiology and Critical Care. One of the founders of MicroVision Medical. Works closely with critical care leaders to develop microcirculation monitoring as a viable tool for clinical decision making support. In charge of an initiative by MicroVision Medical to help clinicians setup clinical investigations and publish their results in acclaimed international medical journals.
Matt Warhoover graduated Vanderbilt University with a Masters in Health Care Management. He also earned a masters in Perfusion Science from Milwaukee School of Engineering. Matt is the current Associate Chief of Perfusion at Vanderbilt University Medical Center. He is the lead for the perfusion based ECMO service line performing nearly 100 ECMO patients and 20,000 hours annually.
His career started as a Cardiac and Thoracic Surgery Anesthesia Technician in 1997 and continued his education and started his perfusion career at Midwest Heart Institute in Milwaukee, WI in 2002. In 2005 Matt moved to Perfusionist Supervisor for McAllen Perfusion Associates, Inc. in McAllen, TX and in 2016 became Associate Chief of Perfusion at Vanderbilt University Medical Center in Nashville, TN.
He is certified with the American Board of Cardiovascular Perfusion and is a Licensed Perfusionist by Tennessee State Department of Health.
He is published in the Journal of Extracorporeal Technology, June, 2008. Publication of Argatroban in Short Term Percutaneous Ventricular Assist Due to Heparin Induced Thrombocytopenia. Matt also presented to the Wisconsin Perfusion Society Meeting – September 2002 – Presentation on the inflammatory response of the utilization of pump suction during primary CABG surgery.
Matt is a member of the American Board of Cardiovascular Perfusion (2002 – Present), Tennessee Perfusion Association Member (2006 – Present) and Tennessee Perfusion Association President (2010 – Present)
Juan Carlos Zubieta, MD, MPH graduated from Universidad Centroccidental in Venezuela in May of 1995. Dr. Zubieta received his MPH from Morehouse School of Medicine in Atlanta, Georgia in May of 1999. Postgraduate Fellowship at Cooper University Medical Center in Camden, New Jersey and Centers for Disease Control and Prevention, CDC in Atlanta, Georgia. Residency and Internship at Mercy Catholic Medical Center in Darby, Pennsylvania.
Dr. Zubieta has practiced as an Attending Intensivist at several institutions including, St. Joseph Medical Center in Houston, Texas, Integris Baptist Medical Center, Memorial Hermann NE and SW, Valley Baptist Medical Center, Freeman Hospital Joplin Missouri, Christus St Michaels Texarkana, Scott & White Healthcare, VA Healthcare System, UPMC, Memorial Hermann NE and The Woodlands. Dr. Zubieta was Assistant Professor at Texas A&M School of Medicine and University of Pittsburgh Medical Center. Dr. Zubieta also held the title of Chief of QA and Education at Centers for Disease Control and Prevention CDC and was the Hospital Coordinator of Venezuela Ministry of Health Rural Physician Primary Care Plus.
Dr. Zubieta is or has been a member of Neuro Critical Care Society, Fellow, American College of Chest Physicians (FCCP) and Society of Critical Care Medicine.
I am an interventional cardiologist with UBMD Cardiovascular Medicine, with specialized training in echocardiography, nuclear cardiology and noninvasive vascular interpretation (RPVI). I see outpatients through the UBMD ambulatory practice at the Amherst Clinic, and I care for patients admitted to the Buffalo General Medical Center (BGMC) consultative service and BGMC’s Cardiac Care Unit (CCU). My interventional practice involves evaluating and caring for patients with coronary and structural heart diseases. I perform diagnostic coronary angiography, percutaneous coronary intervention (PCI), coronary atherectomy, percutaneous mechanical hemodynamic support, cardiac biopsy, patent foramen ovale (PFO)/atrial spetal defect (ASD) closure and transaortic valve replacement (TAVR).
I also have a specialized focus on evaluating and managing patients with peripheral vascular disease, including noninvasive vascular testing and endovascular interventions. I see patients at the Gates Vascular Institute (GVI) where I perform diagnostic peripheral and carotid angiography and interventions for peripheral arterial diseases. These procedures include lower extremity arterial atherectomy, angioplasty and stenting, renal and mesenteric artery revascularization and subclavian intervention.
I am active in research at the GVI by participating in a number clinical trials. One aims at protecting patients from renal damage during PCI (CARIN, Ischemix). Another involves an alternative procedure to perform TAVR for intermediate-risk patients with symptomatic aortic stenosis (SURTAVI, Medtronic). A third clinical trial addresses using intracoronary delivery of stem cells in patients postanterior myocardial infarction with ischemic left ventricular dysfunction (ALLSTAR, Capricor).
As a faculty member at the University at Buffalo, I teach and mentor residents and fellows during their hospital rotations.
Clinical Director | Clinical Education and Support Director | VP Clinical Operations
“Development of Innovative Patient Centered Programs and Excellence in Execution”
An accomplished Clinical Director with expertise in the development and delivery of patient centered programs that consistently provide excellent outcomes. I develop and lead highly effective teams to create innovative clinical support solutions. My background includes strong experience in medical sales and account management.
As Clinical Education and Support Director of the Peripheral Vascular Division of Angiodynamics, I manage a clinical staff of 13 providing organizational goals and strategies to two teams in one division. We develop innovative clinical programs in the area of venous thromboembolic disease. Angiodynamics is a leader, developer, manufacturer and marketer of innovative, propriety minimally invasive devices used by interventionalists and surgeons. Divisions: Vascular Access, Surgery Oncology, Peripheral Vascular.